Document:

<PAGE>

                                                                    EXHIBIT 10.1

                  SERIES A PREFERRED STOCK PURCHASE AGREEMENT

                                 BY AND AMONG

                              MIL 3, INCORPORATED

                           SUMMIT VENTURES IV, L.P.

                                      AND

                          SUMMIT INVESTORS III, L.P.

                        Dated as of September 30, 1997
<PAGE>

                               TABLE OF CONTENTS
                               -----------------
<TABLE>
<CAPTION>
                                                                         Page
<S>                                                                      <C>
                                   ARTICLE I
                          PURCHASE AND SALE OF SHARES

Purchase and Sale of Shares...............................................  1
     1.1    Purchase and Sale of Series A Preferred Stock.................  1
     1.2    The Conversion Shares.........................................  1
     1.3    Closing.......................................................  1
     1.4    Use of Proceeds...............................................  2

                                   ARTICLE II
                 REPRESENTATIONS AND WARRANTIES OF THE COMPANY

Representations and Warranties of the Company.............................  2
     2.1    Organization and Corporate Power..............................  2
     2.2    Authorization.................................................  3
     2.3    Government Approvals..........................................  3
     2.4    Authorized and Outstanding Stock..............................  3
     2.5    Subsidiaries; Certain Investments.............................  4
     2.6    Financial Information.........................................  4
     2.7    Events Subsequent to the Date of the Financial
            Statements....................................................  4
     2.8    Litigation....................................................  5
     2.9    Compliance with Laws and Other Instruments....................  5
     2.10   Taxes.........................................................  6
     2.11   Real Property.................................................  6
     2.12   Personal Property.............................................  6
     2.13   Patents, Trademarks, etc......................................  7
     2.14   Agreements of Directors, Officers and Employees...............  7
     2.15   Governmental and Industrial Approvals.........................  7
     2.16   Federal Reserve Regulations...................................  8
     2.17   Contracts and Commitments.....................................  8
     2.18   Securities Act................................................  8
     2.19   Registration Rights...........................................  8
     2.20   Insurance Coverage............................................  8
     2.21   Employee Matters..............................................  8
     2.22   No Brokers or Finders.........................................  9
     2.23   Transactions with Affiliates..................................  9
     2.24   Assumptions, Guarantees, etc. of Indebtedness
            of Other Persons..............................................  9
     2.25   Disclosures...................................................  9
 </TABLE>

                                       i
<PAGE>

<TABLE>
<S>                                                                        <C>
                                 ARTICLE III
                      AFFIRMATIVE COVENANTS OF THE COMPANY

Affirmative Covenants of the Company.....................................   9
     3.1    Accounts.....................................................  10
     3.2    Reports......................................................  10
     3.3    Other Information............................................  10
     3.4    Payment of Taxes.............................................  11
     3.5    Maintenance of Key Man Insurance.............................  11
     3.6    Compliance with Laws, etc....................................  11
     3.7    Inspection...................................................  12
     3.8    Corporate Existence; Ownership of Subsidiaries...............  12
     3.9    Compliance with ERISA........................................  12
     3.10   Reserved.....................................................  12
     3.11   Financings...................................................  12
     3.12   Meetings of the Board of Directors...........................  13
     3.13   Rule 144A Information........................................  12
     3.14   Regular Course of Business...................................  13
     3.15   Purchase of Shares...........................................  13
     3.16   Notice of Qualified Public Offering..........................  13

                                   ARTICLE IV
                       NEGATIVE COVENANTS OF THE COMPANY

Negative Covenants of the Company........................................  13
     4.1    Dealings with Affiliates.....................................  14
     4.2    No Conflicting Agreements....................................  14
     4.3    Restricted Activities........................................  14

                                   ARTICLE V
                 PURCHASE RIGHTS AND SIZE OF BOARD OF DIRECTORS

Purchase Rights and Size of Board of Directors...........................  14
     5.1    Right of Purchase............................................  14
     5.2    Definition of New Securities.................................  14
     5.3    Notice from the Company......................................  15
     5.4    Sale by the Company..........................................  15
     5.5    Size of Board of Directors...................................  15
     5.6    Termination of Rights........................................  15
 </TABLE>

                                      ii
<PAGE>

<TABLE>
<S>                                                                        <C>
                                   ARTICLE VI
                           INVESTMENT REPRESENTATIONS

Investment Representations...............................................  15
     6.1    Representations and Warranties...............................  15
     6.2    Permitted Sales; Legends.....................................  16
     6.3    Confidentiality Agreement....................................  17
     6.4    Mandatory Conversion.........................................  17

                                  ARTICLE VII
                      CONDITIONS OF INVESTORS' OBLIGATION

Conditions of Investors' Obligation......................................  18
     7.1    Effect of Conditions.........................................  18
     7.2    Representations and Warranties...............................  18
     7.3    Performance..................................................  18
     7.4    Certified Documents, etc.....................................  18
     7.5    No Material Adverse Change...................................  18
     7.6    Shareholders' Agreement......................................  18
     7.7    Reserved.....................................................  18
     7.8    Registration Rights Agreement................................  18
     7.9    Amendment to Certificate of Incorporation....................  19
     7.10   Non-Competition Agreements...................................  19
     7.11   Board Election...............................................  19
     7.12   Consents and Waivers.........................................  19

                                  ARTICLE VIII
                     CONDITIONS OF THE COMPANY'S OBLIGATION

Conditions of the Company's Obligation...................................  19
</TABLE>

                                      iii
<PAGE>

<TABLE>
<S>                                                                        <C>
                                   ARTICLE IX
                              CERTAIN DEFINITIONS

Certain Definitions......................................................  19

                                   ARTICLE X
                                  TERMINATION

Termination..............................................................  22
     10.1   Termination by Mutual Written Consent........................  22
     10.2   Termination for Breach or Failure to Satisfy
            Conditions...................................................  22
     10.3   Termination for Delay........................................  22
     10.4   Rights After Termination.....................................  22

                                   ARTICLE XI
                                 MISCELLANEOUS

Miscellaneous............................................................  22
     11.1   Survival of Representations..................................  22
     11.2   Parties in Interest..........................................  23
     11.3   Shares Owned by Affiliates...................................  23
     11.4   Amendments and Waivers.......................................  23
     11.5   Notices......................................................  23
     11.6   Expenses.....................................................  24
     11.7   Counterparts.................................................  24
     11.8   Effect of Headings...........................................  24
     11.9   Adjustments..................................................  25
     11.10  Governing Law................................................  25
</TABLE>

EXHIBITS
--------

A    Amended and Restated Certificate of Incorporation
B    Opinion of Company Counsel
C    Shareholders' Agreement
D    Stock Repurchase Agreement
E    Registration Rights Agreement
F    Non-Competition Agreement
G    Confidentiality Agreement
H    Stock Transfer Agreement
I    Audited Financial Statements

                                      iv
<PAGE>

J    Unaudited Financial Statements

     SCHEDULES
     ---------

1.1  List of Purchasers and Shares to be Purchased

                                       v
<PAGE>

                              September 30, 1997

Summit Ventures IV, L.P.
Summit Investors III, L.P.
c/o Summit Partners
600 Atlantic Avenue
Suite 2800
Boston, Massachusetts 02210
Attn: Bruce R. Evans

Re:  Series A Preferred Stock
     ------------------------

Gentlemen:

     MIL 3, Incorporated, a Delaware corporation (the "Company"), hereby agrees
with you as follows:

                                   ARTICLE I
                          PURCHASE AND SALE OF SHARES
                          ---------------------------

     1.1    Purchase and Sale of Series A Preferred Stock.  At the Closing (as
            ---------------------------------------------
defined in Section 1.3), the Company will sell to you (each an "Investor" and
together the "Investors"), and the Investors will purchase, an aggregate of
144,640 shares of the Company's Series A Convertible Preferred Stock, par value
$.001 per share (the "Series A Preferred Stock"), at a price of $48.40 per
share, for an aggregate purchase price of $7,000,576.00 payable as provided in
Section 1.4.  The Series A Preferred Stock shall have the rights, terms and
privileges set forth in the Amended and Restated Certificate of Incorporation
(the "Certificate of Incorporation") attached hereto as Exhibit A.  The shares
                                                        ---------
of Series A Preferred Stock purchased pursuant to this Section 1.1 are sometimes
referred to herein as the "Purchased Shares."  The number of Purchased Shares to
be sold by the Company to, and to be purchased by, each Investor is set forth in
Schedule 1.1 attached hereto.
------------

     1.2    The Conversion Shares.  The Company has authorized and reserved and
            ---------------------
hereby covenants that it will continue to reserve, free of any preemptive rights
or encumbrances, a sufficient number of its authorized but unissued shares of
common stock, par value $.01 per share (the "Common Stock"), to satisfy the
rights of conversion of the holders of the Purchased Shares in accordance with
the terms of the Certificate of Incorporation.  The shares of Common Stock
issued or issuable upon conversion of the Purchased Shares are sometimes
referred to herein as the "Conversion Shares."

     1.3    Closing.  Subject to the satisfaction or waiver of the conditions
            -------
set forth in Articles VII and VIII hereof, the sale and purchase of the
Purchased Shares shall be made at a

                                       1
<PAGE>

closing (the "Closing") to be held at the offices of Verner, Liipfert, Bernhard,
McPherson & Hand, Chartered, 901 15th Street, N.W., Washington, D.C., at 10:00
a.m. on the business day following the date on which each of the conditions to
closing have been satisfied or waived in accordance herewith, or at such other
time and on such other date as the Investors and the Company may mutually agree.
Payment at the Closing for the Purchased Shares shall be by wire transfer in
immediately available federal funds to the Company's account at Riggs National
Bank of Washington listed on Schedule 1.3 attached hereto. Each Investor shall
                             ------------
pay that amount for the Purchased Shares being acquired by it at the Closing as
set forth opposite the name of such Investor on Schedule 1.1 attached hereto. At
                                                ------------
the Closing, the Company will deliver to each Investor a certificate
representing the Purchased Shares purchased by such Investor, issued in such
Investor's name.

     1.4    Use of Proceeds.  The Company may use the proceeds received upon the
            ---------------
sale of the Purchased Shares (i) to repurchase up to an aggregate of 69,483
shares of Common Stock from those persons listed on Schedule 1.4 attached hereto
                                                    ------------
at a repurchase price not in excess of the price per share set forth in such
Schedule, each such person to sell such shares and to receive such consideration
as are set forth opposite the name of such person on Schedule 1.4, (ii) to pay
                                                     ------------
all fees, costs and expenses incurred by the Company in connection with the
transactions contemplated by this Agreement, including, without limitation, the
costs and expenses of the Investors which the Company is obligated to pay
pursuant to Section 11.6 hereof, and/or (iii) for working capital purposes.
Persons from whom Common Stock is repurchased (the "Selling Shareholders") in
accordance with this Section 1.4 shall enter into a Stock Repurchase Agreement
with the Company substantially in the form attached hereto as Exhibit D.  The
                                                              ---------
Company will, promptly following the Closing, provide the Tender Notice to each
of the Selling Shareholders in accordance with such Stock Repurchase Agreements
and shall apply its best efforts to consummate each such repurchase as soon as
practicable in accordance with such agreements.  Any repurchase of the shares of
Common Stock in accordance with this Section 1.4 shall be effected within 180
days after the Closing hereunder.

                                  ARTICLE II
                 REPRESENTATIONS AND WARRANTIES OF THE COMPANY
                 ---------------------------------------------

     In order to induce the Investors to purchase the Purchased Shares, the
Company makes the following representations and warranties which shall be true,
correct and complete in all respects on the date hereof and as of the Closing:

     2.1    Organization and Corporate Power.  The Company is a corporation duly
            --------------------------------
organized, validly existing and in good standing under the laws of Delaware and
has all requisite corporate power and authority to own its properties and to
carry on its business as presently conducted.  The Company is duly licensed or
qualified to do business as a foreign corporation in each jurisdiction where the
absence of such license or qualification, if required, would have a material
adverse effect on the business, condition (financial or other), assets,
properties or operations of the Company.

                                       2
<PAGE>

     2.2    Authorization.  The Company has all necessary corporate power and
            -------------
has taken all necessary corporate action required for the due authorization,
execution, delivery and performance by the Company of this Agreement, the
Shareholders' Agreement attached hereto as Exhibit C, the Registration Rights
                                           ---------
Agreement (the "Registration Rights Agreement") attached hereto as Exhibit E,
                                                                   ---------
the Non-Competition Agreements attached hereto as Exhibit F, and  the
                                                  ---------
Confidentiality Agreement attached hereto as Exhibit G (collectively, the
                                             ---------
"Related Agreements"), and any other agreements or instruments executed or to be
executed by the Company in connection herewith or therewith and the consummation
of the transactions contemplated herein or therein, and for the due
authorization, issuance and delivery of the Purchased Shares, and the Conversion
Shares issuable upon conversion of the Purchased Shares.  Sufficient shares of
authorized but unissued Common Stock have been reserved for issuance upon
conversion of the Purchased Shares.  The issuance of the Purchased Shares is not
and will not be subject to any preemptive right, right of first refusal or the
like.  Assuming due execution and delivery by each of the Investors of this
Agreement and the Related Agreements to which either of the Investors is a
party, this Agreement, the Related Agreements and the other agreements and
instruments executed by the Company in connection herewith or therewith will
each be a valid and binding obligation of the Company enforceable in accordance
with its respective terms.

     2.3    Government Approvals.  No consent, approval, license or
            --------------------
authorization of, or designation, declaration or filing with, any court or
governmental authority is or will be required on the part of the Company in
connection with the execution, delivery and performance by the Company of this
Agreement, any of the Related Agreements and any other agreements or instruments
executed by the Company in connection herewith or therewith, or in connection
with the issuance of the Purchased Shares or the issuance of the Conversion
Shares upon conversion of the Purchased Shares, except for (i) those which have
already been made or granted, (ii) the filing of the Certificate of
Incorporation with the Secretary of State of the State of Delaware, and (iii)
the filing of registration statements with the Securities and Exchange
Commission (the "Commission") and of such registration statements and related
documents with any applicable state securities commission as specifically
contemplated in the Registration Rights Agreement attached hereto as Exhibit E.
                                                                     ---------

     2.4    Authorized and Outstanding Stock.  At the Closing, the authorized
            --------------------------------
capital stock of the Company will consist of (i) 2,000,000 shares of Common
Stock, of which 778,250 shares are validly issued and outstanding and held of
record and owned beneficially as set forth in Schedule 2.4 attached hereto, and
                                              ------------
of which 339,020 shares are held by the Company as treasury shares, and (ii)
400,000 shares of Preferred Stock, of which 160,000 shares will have been
designated as Series A Preferred Stock with the rights, terms and privileges set
forth in the Certificate of Incorporation and of which 144,640 shares of Series
A Preferred Stock will, upon consummation of the Closing, be issued and
outstanding.  All issued and outstanding shares of capital stock are, and when
issued in accordance with the terms hereof, all Purchased Shares and Conversion
Shares issued upon conversion of the Purchased Shares will be, duly and validly
authorized, validly issued and fully paid and non-assessable and free from any
restrictions on

                                       3
<PAGE>

transfer, except for restrictions imposed (i) by federal or state securities or
"blue-sky" laws, (ii) pursuant to this Agreement, any Related Agreement or
created by any of the Investors, (iii) solely with respect to shares other than
Purchased Shares or Conversion Shares, under stock option or similar agreements
between the Company and its employees, or (iv) pursuant to those certain Stock
Transfer Agreement (copies of which are attached hereto as Exhibit H), the
                                                           ---------
Shareholders Agreement, or the Stock Purchase and Option Agreement between the
Company, on one hand, and each of the persons listed on Schedule 2.4, on the
                                                        ------------

other hand. Except as set forth on Schedule 2.4, there are no outstanding
                                   ------------
warrants, options, commitments, preemptive rights, rights to acquire or
purchase, conversion rights or demands of any character relating to the capital
stock or other securities of the Company.

     2.5    Subsidiaries; Certain Investments.  The Company has no Subsidiaries.
            ---------------------------------
Except as set forth in Schedule 2.5 attached hereto, the Company has no
                       ------------
investment or other interest in, or any outstanding loan or advance to or from,
any Person, including, without limitation, any officer, director or shareholder
of the Company.

     2.6    Financial Information.  The Company has previously delivered to the
            ---------------------
Investors the  (a) financial statements of the Company for the fiscal year ended
March 31, 1997, audited by Deloitte & Touche, LLP ("Deloitte & Touche"), the
Company's certified public accountants (the "Audited Financial Statements", and
a copy of which is attached hereto as Exhibit I) and (b) the unaudited balance
                                      ---------
sheet of the Company at, and the unaudited interim income statement with
reconciliations for the five months ended, August 31, 1997 (the "Unaudited
Financial Statements", and a copy of which is attached hereto as Exhibit J).
                                                                 ---------
The Audited Financial Statements and the Unaudited Financial Statements
(collectively, the "Financial Statements") are complete and correct, are in
accordance with the books and records of the Company and present fairly in
accordance with generally accepted accounting principles applied on a basis
consistent with prior periods the financial condition and results of operations
of the Company as of the date and for the period shown (except in respect to the
absence of notes and customary year-end adjustments consistent with past
practice relating to the Unaudited Financial Statements).  The Company has no
liability, contingent or otherwise, which is not adequately reflected in or
reserved against in the Financial Statements that could materially and adversely
affect the financial condition of the Company.  Since the date of the Unaudited
Financial Statements, (i) there has been no change in the business, assets,
liabilities, condition (financial or otherwise) or operations of the Company
except for changes in the ordinary course of business which, individually or in
the aggregate, have not been materially adverse, and (ii) none of the business,
condition (financial or otherwise), operations, property or affairs of the
Company has been materially adversely affected by any occurrence or development,
individually or in the aggregate, whether or not insured against.

     2.7    Events Subsequent to the Date of the Financial Statements.  Except
            ---------------------------------------------------------
as contemplated herein, in the Related Agreements, or as set forth on Schedule
                                                                      --------
2.7 attached hereto,  since March 31, 1997,  the Company has not (i) issued any
---
stock, bond or other corporate security, (ii) borrowed any amount or incurred or
become subject to any liability (absolute, accrued or contingent), except
liabilities in the ordinary course of business, (iii) discharged or

                                       4
<PAGE>

satisfied any lien or encumbrance or incurred or paid any obligation or
liability (absolute, accrued or contingent) other than current liabilities shown
on the Financial Statements and current liabilities incurred since March 31,
1997 in the ordinary course of business, (iv) declared or made any payment or
distribution to stockholders or purchased or redeemed any shares of its capital
stock or other securities, (v) mortgaged, pledged or subjected to lien any of
its assets, tangible or intangible, other than liens of current real property
taxes not yet due and payable, (vi) sold, assigned or transferred any of its
tangible assets except in the ordinary course of business, or canceled any debt
or claim, except in the ordinary course of business, (vii) sold, assigned,
transferred or granted any license with respect to any patent, trademark, trade
name, service mark, copyright, trade secret or other intangible asset, except
pursuant to license or other agreements entered into in the ordinary course of
business, (viii) suffered any loss of property or waived any right of
substantial value whether or not in the ordinary course of business, (ix) made
any change in officer compensation, (x) made any material change in the manner
of business or operations of the Company, (xi) entered into any transaction
except in the ordinary course of business or as otherwise contemplated hereby or
(xii) entered into any commitment (contingent or otherwise) to do any of the
foregoing.

     2.8    Litigation.  Except as otherwise set forth on Schedule 2.8 attached
            ----------                                    ------------
hereto, there is no litigation or governmental proceeding or investigation,
pending or, to the Company's knowledge, threatened, against the Company or
affecting any of the Company's properties or assets, or against any officer, key
employee or shareholder of the Company in his capacity as such, nor, to the
Company's knowledge, has there occurred any event or does there exist any
condition on the basis of which any litigation, proceeding or investigation
might properly be instituted with any substantial chance of recovery where such
recovery would likely have a material adverse effect on the Company.  Neither
the Company, nor any officer, key employee or shareholder of the Company in his
capacity as such is, to the knowledge of the Company, in default with respect to
any order, writ, injunction, decree, ruling or decision of any court,
commission, board or other government agency which may materially and adversely
affect the business or assets of the Company.

     2.9    Compliance with Laws and Other Instruments.  Except as set forth on
            ------------------------------------------
Schedule 2.9 attached hereto, the Company is in compliance with all of the
------------
provisions of this Agreement and of its certificate of incorporation and by-
laws, and in all material respects with the provisions of each mortgage,
indenture, lease, license, other agreement or instrument, judgment, decree,
judicial order, statute, and regulation by which it is bound or to which it or
any of  its properties is subject.  Neither the execution, delivery or
performance of this Agreement and the Related Agreements, nor the offer,
issuance, sale or delivery of the Purchased Shares, or the Conversion Shares
upon conversion of the Purchased Shares, with or without the giving of notice or
passage of time, or both, will violate, or result in any breach of, or
constitute a default under, or result in the imposition of any encumbrance upon
any asset of the Company pursuant to any provision of the Company's certificate
of incorporation or by-laws, or any statute, rule or regulation, contract,
lease, judgment, decree or other document or instrument by which the Company is
bound or to which the Company or any of its respective properties is subject, or
will cause the Company to

                                       5
<PAGE>

lose the benefit of any right or privilege it presently enjoys or cause any
Person who is expected normally to do business with the Company to discontinue
to do so on the same basis.

     2.10   Taxes.  The Company has filed all tax returns (including statements
            -----
of estimated taxes owed) required to be filed within the applicable periods for
such filings and has paid all taxes required to be paid, and has established
adequate reserves (net of estimated tax payments already made) for the payment
of all taxes payable in respect to the period subsequent to the last periods
covered by such returns.  No deficiencies for any tax are currently assessed
against the Company and, except as set forth on Schedule 2.10 attached hereto,
                                                -------------
no tax returns of the Company have ever been audited and, to the knowledge of
the Company, there is no such audit pending or contemplated.  There is no tax
lien, whether imposed by any federal, state or local taxing authority,
outstanding against the assets, properties or business of the Company.  For the
purposes of this Agreement, the term "tax" shall include all federal, state and
local taxes, including income, franchise, property, sales, withholding, payroll
and employment taxes.

     2.11   Real Property.
            -------------

            (a) The Company owns no real property.  Schedule 2.11 attached
                                                    -------------
hereto sets forth the addresses and uses of all real property that the Company
leases or subleases, and any lien or encumbrance on the Company's leasehold
interest therein, specifying in the case of each such lease or sublease, the
name of the lessor or sublessor, as the case may be, the lease term and the
rental obligations of the lessee thereunder.

            (b) Except as set forth on Schedule 2.11, there is no material
                                       -------------
violation by the Company of any law, regulation or ordinance (including without
limitation laws, regulations or ordinances relating to zoning, environmental,
city planning or similar matters) relating to any real property leased or
subleased by the Company.

            (c) There are no defaults by the Company or, to the knowledge of the
Company, by any other party thereto, which might curtail in any material respect
the present use of the Company's leased or subleased real property listed on
Schedule 2.11.  The performance by the Company of this Agreement and the Related
-------------
Agreements will not result in the termination of, or in any increase of any
amounts payable under, any lease listed on Schedule 2.11.
                                           -------------

     2.12   Personal Property.  Except as set forth on Schedule 2.12 attached
            -----------------                          -------------
hereto and except for property sold or otherwise disposed of in the ordinary
course of business since March 31, 1997, the Company owns free and clear of any
liens or encumbrances, all of the personal property reflected as owned by the
Company in the balance sheet contained in the Financial Statements, and all
other material items of personal property acquired by the Company through the
date hereof.  All material items of such personal property are in operating
condition, normal wear and tear excepted.

                                       6
<PAGE>

     2.13   Patents, Trademarks, etc.  Set forth on Schedule 2.13 attached
            -------------------------               -------------
hereto is a list and brief description of all material patents, patent rights,
patent applications, trademarks, trademark applications, service marks, service
mark applications, trade names and copyrights, and all applications for such
that are in the process of being prepared, owned by or registered in the name of
the Company, or of which the Company is a licensor or licensee or in which the
Company has any right.  To the best knowledge of the Company, the Company owns
and possesses rights to use all patents, patent applications, trademarks,
trademark applications, service marks, service mark applications, trade names,
copyrights, manufacturing processes, formulae, trade secrets and know how
(collectively, "Intellectual Property") necessary to the conduct of its business
as conducted and as proposed to be conducted.  No claim is pending or, to the
knowledge of the Company threatened, to the effect that the operations of the
Company infringe upon or conflict with the asserted rights of any other person
under any Intellectual Property, and there is no basis known to the Company for
any such claim (whether or not pending or threatened).  No claim is pending or,
to the knowledge of the Company,  threatened, to the effect that any such
Intellectual Property owned or licensed by the Company, or which the Company
otherwise has the right to use, is invalid or unenforceable by the Company, and
there is no basis known to the Company for any such claim (whether or not
pending or threatened).  All material confidential technical information
developed by and belonging to the Company which has not been patented or
copyrighted has been protected against unauthorized use or disclosure in
accordance with standards prevailing in the industry in which the Company
operates.  Except as set forth on Schedule 2.13, the Company has not granted or
                                  -------------
assigned to any other person or entity any right to manufacture, have
manufactured, assemble or sell the products or proposed products or to provide
the services or proposed services of the Company.  No current or former
stockholder, employee, officer or director of the Company has (directly or
indirectly) any right, title or interest in any of the rights described on
Schedule 2.13 other than such right which such Person may enjoy as a stockholder
-------------
of the Company.

     2.14   Agreements of Directors, Officers and Employees.  To the knowledge
            -----------------------------------------------
of the Company, no director, officer or employee of the Company is in violation
of any terms of any employment contract, non-competition agreement, non-
disclosure agreement, patent disclosure or assignment agreement or other
contract or agreement containing restrictive covenants relating to the right of
any such director, officer or employee to be employed or engaged by the Company
because of the nature of the business conducted or proposed to be conducted by
the Company, or relating to the use of trade secrets or proprietary information
of others.

     2.15   Governmental and Industrial Approvals.  The Company has all the
            -------------------------------------
material permits, licenses, orders, franchises and other rights and privileges
of all federal, state, local or foreign governmental or regulatory bodies
necessary for the Company to conduct its business as presently conducted.  All
such permits, licenses, orders, franchises and other rights and privileges are
in full force and effect and no suspension or cancellation of any of them is, to
the knowledge of the Company, threatened, and none of such permits, licenses,
orders, franchises or other rights and privileges will be adversely affected by
the consummation of the transactions contemplated in this Agreement and the
Related Agreements.

                                       7
<PAGE>

     2.16   Federal Reserve Regulations.  The Company has not engaged in the
            ---------------------------
business of extending credit for the purpose of purchasing or carrying margin
stock (within the meaning of Regulation G of the Board of Governors of the
Federal Reserve System), and no part of the proceeds of the sale of the
Purchased Shares will be used by the Company to purchase or carry any margin
security or to extend credit to others for the purpose of purchasing or carrying
any margin security or in any other manner which would involve a violation of
any of the regulations of the Board of Governors of the Federal Reserve System.

     2.17   Contracts and Commitments.  Except as referred to in this Agreement
            -------------------------
or as set forth on Schedule 2.17 attached hereto, the Company has no contract,
                   -------------
obligation or commitment (including to make or receive royalties) which is
material or which involves a potential material commitment or any stock
redemption or stock purchase agreement, financing agreement, license, lease, or
stock option plan.  For purposes of this Section 2.17, a contract, obligation or
commitment shall be deemed material if it requires future expenditures by the
Company in excess of $250,000 or might result in payments to the Company in
excess of $500,000.

     2.18   Securities Act.  The Company has complied and will comply with all
            --------------
applicable federal or state securities laws in connection with the issuance and
sale of the Purchased Shares and the issuance of the Conversion Shares upon
conversion of the Purchased Shares.  Neither the Company nor anyone acting on
its behalf has offered any of the Purchased Shares, or similar securities, or
solicited any offers to purchase any of such securities, so as to require the
issuance and sale of the Purchased Shares to be registered under the
registration provisions of the Act.

     2.19   Registration Rights.  The Company has not granted any rights
            -------------------
relating to registration of its capital stock under the Act or state securities
laws other than those to be contained in the Registration Rights Agreement.

     2.20   Insurance Coverage.  Schedule 2.20 attached hereto contains an
            ------------------   -------------
accurate summary of the insurance policies currently maintained by the Company.
Except as described on Schedule 2.20, there are currently no claims in excess of
                       -------------
$10,000 pending against the Company under any insurance policies currently in
effect and covering the property, business or employees of the Company, and all
premiums due and payable with respect to the policies maintained by the Company
have been paid to date.

     2.21   Employee Matters.  Except as set forth on Schedule 2.21 attached
            ----------------                          -------------
hereto, the Company does not have in effect any employment agreements,
consulting agreements, deferred compensation, pension or retirement agreements
or arrangements, bonus, incentive or profit-sharing plans or arrangements, or
labor or collective bargaining agreements, written or oral.  To the knowledge of
the Company, no officers or other key employees of the Company presently intends
to terminate his employment.  The Company is in compliance in all material
respects with all applicable laws and regulations relating to labor, employment,
fair employment practices, terms and conditions of employment, and wages and
hours.  The Company is in material compliance

                                       8
<PAGE>

with the terms of all plans, programs and agreements listed on Schedule 2.21,
                                                               -------------
and each such plan, program or agreement is in compliance with all of the
material requirements and provisions of the Employee Retirement Income Security
Act of 1974, as amended ("ERISA"). No such plan or program has engaged in any
"prohibited transaction" as defined in Section 4975 of the Internal Revenue Code
of 1986 (the "Code"), or has incurred any "accumulated funding deficiency" as
defined in Section 302 of ERISA, nor has any reportable event as defined in
Section 4043(b) of ERISA occurred with respect to any such plan or program. With
respect to each plan listed on Schedule 2.21, all required filings, including
                               -------------
all filings required to be made with the United States Department of Labor and
Internal Revenue Service, have been timely filed.

     2.22   No Brokers or Finders.  No person has or will have, as a result of
            ---------------------
the Company's issuance and sale of the Purchased Shares or the Conversion Shares
in accordance with this Agreement, any right, interest or claim against or upon
the Company for any commission, fee or other compensation as a finder or broker
because of any act or omission by the Company.

     2.23   Transactions with Affiliates.  Except as contemplated in this
            ----------------------------
Agreement or the Related Agreements or as set forth on Schedule 2.23 attached
                                                       -------------
hereto, there are no loans, leases or other continuing transactions (including
without limitation agreements or other transactions involving any significant
intellectual property of the Company) between the Company on the one hand, and
any officer or director of the Company or any person owning ten percent (10%) or
more of the Common Stock of the Company or any respective family member or
affiliate of such officer, director or shareholder on the other hand.  The
current annual compensation (inclusive of salary and bonus) for each of Alain J.
Cohen and Marc A. Cohen is $270,000 and $270,000, respectively, and each also
receives benefits from the Company consisting of life, health and disability
insurance.

     2.24   Assumptions, Guarantees, etc. of Indebtedness of Other Persons.  The
            --------------------------------------------------------------
Company has not assumed, guaranteed, endorsed or otherwise become directly or
contingently liable on or for any indebtedness of any other Person, except
guarantees by endorsement of negotiable instruments for deposit or collection or
similar transactions in the ordinary course of business.

     2.25   Disclosures.  Neither this Agreement, any Schedule or Exhibit to
            -----------
this Agreement, the Related Agreements, the Financial Statements nor any other
agreement, document or written statement made by the Company and furnished by
the Company to the Investors or the Investors' counsel in connection with the
transactions contemplated hereby, contains any untrue statement of material fact
or omits to state any material fact necessary to make the statements contained
herein or therein not misleading.

                                  ARTICLE III
                     AFFIRMATIVE COVENANTS OF THE COMPANY
                     ------------------------------------

     Without limiting any other covenants and provisions hereof, the Company
covenants and agrees that it will observe the following covenants on and after
the Closing, as long as any of the

                                       9
<PAGE>

Purchased Shares are outstanding, except where any covenant is specifically
qualified by reference to a specified number of Purchased Shares, in which event
the Company will observe such covenant only so long as such specified percentage
of the Purchased Shares is outstanding:

     3.1    Accounts.  The Company will, and will cause each of its Subsidiaries
            --------
to, maintain a standard system of accounts in accordance with generally accepted
accounting principles consistently applied and the Company will, and will cause
each of its Subsidiaries to,  keep full and complete financial records.

     3.2    Reports.  Provided that at least 15% of the Purchased Shares
            -------
(excluding any Conversion Shares) is outstanding, the Company will furnish to
each Investor the information set forth in this Section 3.2:

            (a) Within ninety (90) days after the end of each fiscal year, a
copy of the consolidated and consolidating balance sheet of the Company and its
Subsidiaries as at the end of such year, together with consolidated and
consolidating statements of income, shareholders' equity and cash flow of the
Company and its Subsidiaries for such year, setting forth in each case in
comparative form the corresponding figures for the preceding fiscal year, all in
reasonable detail and duly certified by an independent public accountant of
national recognition selected by the Board of Directors of the Company.

            (b) Within thirty (30) days after the end of each calendar month, a
preliminary consolidated and consolidating balance sheet of the Company and its
Subsidiaries as of the end of such month and preliminary consolidated and
consolidating statements of income, shareholders' equity and cash flow for such
month and for the period commencing at the end of the previous fiscal year and
ending with the end of such month, setting forth in each case in comparative
form the corresponding figures for the corresponding period of the preceding
fiscal year, all in reasonable detail.

            (c) Prior to the end of each fiscal year, a copy of an annual
proposed summary budget and statement of objectives for the next fiscal year.

            (d) Promptly upon receipt thereof, any written report, so called
"management letters," and any other written communication submitted to the
Company or any Subsidiary by its independent public accountants relating to the
business, prospects or financial condition of the Company and its Subsidiaries.

     3.3    Other Information.  The Company will furnish to each Investor the
            -----------------
information set forth in this Section 3.3:

            (a) Promptly after the commencement thereof, notice of (i) all
actions, suits and proceedings before any court or governmental department,
commission, board, bureau, agency or instrumentality, domestic or foreign,
affecting the Company (or any Subsidiary) which,

                                       10
<PAGE>

if successful, could have a material adverse effect on the Company and its
Subsidiaries, taken as a whole; and (ii) all material defaults by the Company or
any Subsidiary (whether or not declared) under any agreement for money borrowed
(unless waived or cured within applicable grace periods);

            (b) Promptly upon sending, making available, or filing the same, all
reports and financial statements as the Company (or any Subsidiary) shall send
or make available generally to the shareholders of the Company as such or to the
Commission; and

            (c) Such other information with regard to the business, properties
or the condition or operations, financial or otherwise, of the Company or its
Subsidiaries as is readily available to the Company without unreasonable effort
and expense and as the Investors may from time to time reasonably request.

     3.4    Payment of Taxes.  The Company will pay and discharge (and cause any
            ----------------
Subsidiary to pay and discharge) all taxes, assessments and governmental charges
or levies imposed upon it or upon its income or profits, or upon any properties
belonging to it, prior to the date on which penalties attach thereto, and all
lawful claims which, if unpaid, might become a lien or charge upon any
properties of the Company (or any Subsidiary), provided that neither the Company
nor any Subsidiary shall be required to pay any such tax, assessment, charge,
levy or claim which is being contested in good faith and by proper proceedings
if the Company or such Subsidiary shall have set aside on its books adequate
reserves with respect thereto.

     3.5    Maintenance of Key Man Insurance.  The Company shall, at its
            --------------------------------
expense, use its reasonable best efforts to obtain within thirty (30) days after
the Closing and thereafter so long as at least 15% of the Purchased Shares
(excluding any Conversion Shares) is outstanding shall maintain, a life
insurance policy with a responsible and reputable insurance company payable to
the Company on the lives of Marc A. Cohen (as long as he remains an officer or
employee or is actively involved in the day-to-day operations of the Company)
and Alain J. Cohen (as long as he remains an officer or employee or is actively
involved in the day-to-day operations of the Company), each such policy in the
face amount of $2.0 million.  The Company will not cause or permit any
assignment of the proceeds of such policies and will not borrow against such
policies.  The Company will add one designee of the Investor as a notice party
to each such policy, and will request that the issuer of each such policy
provide such designee with ten (10) days' notice before such policy is
terminated (for failure to pay premium or otherwise) or assigned, or before any
change is made in the designation of the beneficiary thereof.

     3.6    Compliance with Laws, etc.  The Company will comply (and cause each
            --------------------------
of its Subsidiaries to comply) with all applicable laws, rules, regulations and
orders of any governmental authority, the noncompliance with which could
materially adversely affect the business or condition, financial or otherwise,
of the Company and its Subsidiaries, taken as a whole.

                                       11
<PAGE>

     3.7    Inspection.  At any reasonable time during normal business hours and
            ----------
from time to time, but not more frequently than once per calendar quarter for
all Investors and transferees of Investors as a group, upon five (5) days'
written notice, the Company (and each of its Subsidiaries) will permit any one
or more of the Investors who then own, of record or beneficially, or have the
right to acquire, any of the Conversion Shares, or any transferee of an Investor
who owns, of record or beneficially, or has the right to acquire, at least five
percent (5%) of the then outstanding Common Stock, or any of the agents or
representatives of the foregoing Persons, to examine and make copies of and
extracts from the records and books of account of and visit the properties of
the Company (and any of its Subsidiaries) and to discuss the Company's affairs,
finances and accounts with any of its officers or directors; provided, however,
                                                             --------  -------
that any Person or Persons exercising rights under this Section 3.7 shall (i)
use all reasonable efforts to ensure that any such examination or visit results
in a minimum of disruption to the operations of the Company and (ii) shall agree
in writing to keep any proprietary information of the Company disclosed to it in
the course of such inspection confidential in accordance with the
Confidentiality Agreement (substantially in the form of Exhibit G) executed (or
                                                        ---------
with respect to any transferee, to be executed and delivered to the Company as a
condition precedent to the exercise of such inspection rights) by such Person
and not use such proprietary information for any purpose in competition with the
Company's business.  The rights granted under this Section 3.7 shall be in
addition to any rights which any Investor may have under applicable law in its
capacity as a shareholder of the Company.

     3.8    Corporate Existence; Ownership of Subsidiaries.  The Company will,
            ----------------------------------------------
and will cause its Subsidiaries to, at all times preserve and keep in full force
and effect their corporate existence, and rights and franchises material to the
business of the Company and its Subsidiaries, taken as a whole, and will
qualify, and will cause each of its Subsidiaries to qualify, to do business as a
foreign corporation in any jurisdiction where the failure to do so would have a
material adverse effect on the business, condition (financial or other), assets,
properties or operations of the Company and its Subsidiaries, taken as a whole.

     3.9    Compliance with ERISA.  The Company will comply (and cause each of
            ---------------------
its Subsidiaries to comply) in all material respects with all minimum funding
requirements applicable to any pension or other employee benefit plans which are
subject to ERISA or to the Code, and comply in all other material respects with
the provisions of ERISA and the Code, and the rules and regulations thereunder,
which are applicable to any such plan.  Neither the Company nor any of its
Subsidiaries will permit any event or condition to exist which could permit any
such plan to be terminated under circumstances which cause the lien provided for
in Section 3068 of ERISA to attach to the assets of the Company or any of its
Subsidiaries.

     3.10   Reserved.
            --------

     3.11   Financings.  The Company will promptly provide to the Board of
            ----------
Directors the details and terms of, and any brochures, registration statements
or investment memoranda prepared by the Company related to, any possible
financing of any nature for the Company (or any of its Subsidiaries), whether
initiated by the Company or any other Person.

                                       12
<PAGE>

     3.12   Meetings of the Board of Directors.  The Board of Directors shall
            ----------------------------------
hold regular meetings not less frequently than once every 90 days.

     3.13   Rule 144A Information.  The Company shall, upon the written request
            ---------------------
of any Investor, provide to such Investor and to any prospective qualified
institutional buyer (as defined in Rule 144A under the Act) from the Investor of
the Purchased Shares or Conversion Shares designated by such Investor,  such
financial and other information concerning the Company as is immediately
available to the Company and that can be obtained by the Company without undue
effort or expense and as such Investor may reasonably determine is required to
permit such prospective sale to such qualified institutional buyer to comply
with the requirements of Rule 144A promulgated under the Act, provided, that
                                                              --------
prior to such disclosure, such qualified institutional buyer first enters into a
confidentiality agreement with the Company substantially in the form of the
Confidentiality Agreement attached hereto as Exhibit G.
                                             ---------

     3.14   Regular Course of Business.  The Company agrees that on and after
            --------------------------
the date hereof and prior to the Closing that it will carry on its business
diligently and in the ordinary course and substantially in the same manner as
heretofore carried on and will use its reasonable best efforts to preserve its
present business organization intact, keep available the services of its present
officers, agents and employees and preserve its present relationships with
suppliers, customers and other persons having business dealings with it.

     3.15   Purchase of Shares.   Until 180 days after the Closing, the Company
            ------------------
shall have the option to seek to and to repurchase up to an aggregate of 69,483
shares of Common Stock from the  shareholders of the Company listed on Schedule
                                                                       --------
l.4 in accordance with Section 1.4 hereof, and the stock certificates
---
representing such shares as shall be so repurchased shall be canceled and
retired.

     3.16   Notice of Qualified Public Offering. The Company shall provide the
            -----------------------------------
Investors with thirty (30) days' prior notice of the filing of a registration
statement under the Act which contemplates a Qualified Public Offering.

                                  ARTICLE IV
                       NEGATIVE COVENANTS OF THE COMPANY
                       ---------------------------------

     Without limiting any other covenants and provisions hereof, the Company
covenants and agrees that it will comply (and will cause each Subsidiary to
comply) with each of the provisions of this Article IV on and after the date
hereof and until the consummation of the first Qualified Public Offering;
provided, however, that the provisions of Section 4.1 shall continue in force
--------  -------
only so long as there are Purchased Shares outstanding and the provisions of
Section 4.3 shall continue in force only as stated therein.

                                       13
<PAGE>

     4.1    Dealings with Affiliates.  The Company will not enter into any
            ------------------------
transaction including, without limitation, any loans or extensions of credit or
royalty agreements with any officer or director of the Company or any Subsidiary
or holder of five percent (5%) or more of any class of capital stock of the
Company, or any member of their respective immediate families or any corporation
or other entity directly or indirectly controlled by one or more of such
officers, directors or shareholders or members of their immediate families,
except on terms no less favorable to the Company than could be obtained from an
unaffiliated third party as determined by a majority of the disinterested
directors of the Company.

     4.2    No Conflicting Agreements.  The Company agrees that neither it nor
            -------------------------
any Subsidiary will, without the consent of the Investors, enter into or amend
any agreement, contract, commitment or understanding which would restrict or
prohibit the exercise by the Investors of any of their rights under this
Agreement or any of the Related Agreements, nor amend or waive any provisions of
the Stock Repurchase Agreements with those persons referred to on Schedule 1.4.
                                                                  ------------

     4.3    Restricted Activities.  The Company agrees that on and after the
            ---------------------
date hereof and prior to Closing it will not take any action that would require
disclosure under Section 2.7 of this Agreement.

                                   ARTICLE V
                PURCHASE RIGHTS AND SIZE OF BOARD OF DIRECTORS
                ----------------------------------------------

     5.1    Right of Purchase.  The Company hereby grants to the Investors so
            -----------------
long as the Investors collectively shall own, of record and beneficially, at
least 33% of the Purchased Shares (not including Conversion Shares or other
Common Stock), the right to purchase all or part of their pro rata share of New
Securities (as defined in Section 5.2) which the Company, from time to time,
proposes to sell and issue. An Investor's pro rata share, for purposes of this
Article V, is, at the time of determination, the ratio of (a) the number of
shares of Common Stock issuable upon conversion of the number of Purchased
Shares which such Investor then owns to (b) the sum of the number of shares of
Common Stock issuable upon conversion of all Purchased Shares then outstanding
plus the number of shares of Common Stock then outstanding. The Investors shall
have a right of over-allotment pursuant to this Article V such that to the
extent an Investor does not exercise its pro rata purchase right in full
                                         --- ----
hereunder, such shares of New Securities which such Investor had the right to
but did not purchase may be purchased by the other Investor.

     5.2    Definition of New Securities.  "New Securities" shall mean any
            ----------------------------
capital stock of the Company whether now authorized or not, and rights, options
or warrants to purchase capital stock, and securities of any type whatsoever
that are, or may become convertible into or exchangeable for capital stock,
issued on or after the Closing; provided that the term "New Securities" does not
                                --------
include (a) securities issued in a public offering whether or not it is a
Qualified Public Offering; (b) securities purchased under this Agreement or
Conversion Shares issuable upon conversion of the Purchased Shares; (c) Common
Stock issued as a stock dividend to holders of Common Stock or upon any stock
split, subdivision or combination of shares of

                                       14
<PAGE>

Common Stock; (d) Series A Preferred Stock issued as a dividend to holders of
the Series A Preferred Stock or upon any stock split, subdivision or combination
of the Series A Preferred Stock; and (e) up to an aggregate of the number of
shares of Common Stock equal to the sum of (i) 200,000 shares issuable upon
exercise of options governed by the Company's 1995 Incentive Stock Option Plan,
plus (ii) the 10,000 shares issuable to George M. Cathey in accordance with
other agreements listed in Schedule 2.4.
                           ------------

     5.3    Notice from the Company. In the event the Company proposes to
            -----------------------
undertake an issuance of New Securities, it shall give each Investor written
notice of its intention, describing the type of New Securities and the price and
the terms upon which the Company proposes to issue the same. The Investors shall
have 20 business days from the date of receipt of any such notice to agree to
purchase their aggregate pro rata share of such New Securities for the price and
upon the terms specified in the notice by giving written notice to the Company
and stating therein the quantity of New Securities to be purchased.

     5.4    Sale by the Company. In the event the Investors fail to exercise in
            -------------------
full their right to purchase their aggregate pro rata share of New Securities,
the Company shall have 120 days thereafter to sell the New Securities with
respect to which the Investors' right was not exercised, at a price and upon
terms no more favorable to the purchaser thereof than specified in the Company's
notice. To the extent the Company does not sell all the New Securities offered
within said 120 day period, the Company shall not thereafter issue or sell such
New Securities without first again offering such securities to the Investors in
the manner provided above.

     5.5    Size of Board of Directors. As long as the Investors collectively
            --------------------------
shall own, of record and beneficially, at least 33% of the Purchased Shares
(excluding Conversion Shares or other Common Stock), the size of the Board of
Directors shall not exceed seven members.

     5.6    Termination of Rights.  The rights granted to the Investors under
            ---------------------
this Article V are not transferrable or assignable to any Person and shall
expire and be of no further force or effect immediately on the earliest of (i)
such date that the Investors no longer collectively own of record and
beneficially at least 33% of the Purchased Shares (not including Conversion
Shares or other Common Stock), or (ii) the consummation of a Qualified Public
Offering.

                                  ARTICLE VI
                          INVESTMENT REPRESENTATIONS
                          --------------------------

     6.1    Representations and Warranties.  In order to induce the Company to
            ------------------------------
offer for sale and sell the Purchased Shares and the Conversion Shares, each
Investor hereby makes the following representations and warranties which shall
be true, correct and complete in all respects as of the Closing and as of the
date of delivery of any Conversion Shares:

          (a) Assuming due execution and delivery by the Company of this
Agreement and the Related Agreements, this Agreement and the Related Agreements
to which such Investor

                                       15
<PAGE>

is a party constitute legal, valid and binding obligations of such Investor,
enforceable against such Investor in accordance with their respective terms;

          (b) Such Investor has been advised and understands that the Purchased
Shares have not been, and the Conversion Shares and any New Securities will not
be, registered under the Act or the securities laws of any jurisdiction, and
that in this connection, the Company is relying in part on the representations
of such Investor set forth in this Article VI;

          (c) Such Investor has been further advised and understands that no
public market now exists for any of the securities issued by the Company and
that a public market may never exist for the Purchased Shares, Conversion Shares
and any New Securities;

          (d) Such Investor is purchasing the Purchased Shares, and to the
extent it acquires any Conversion Shares or any New Securities is or will be
acquiring such Conversion Shares or New Securities, as the case may be, for
investment purposes, for its own account and not with a view to, or for sale in
connection with, any distribution thereof in violation of federal or state
securities laws;

          (e) By reason of its business or financial experience, such Investor
has the capacity to protect its own interest in connection with the transactions
contemplated hereunder;

          (f) Such Investor is aware of the Company's business affairs and
financial condition and has had an opportunity to ask questions and receive
answers from the Company's management and has acquired sufficient information
about the Company to reach an informed and knowledgeable decision to acquire the
Purchased Shares and, as applicable, to acquire any Conversion Shares or New
Securities; provided, however, that nothing in this Section 6.1 shall be deemed
            --------  -------
to vitiate or limit the representations, warranties and covenants of the Company
contained in this Agreement;

          (g) Such Investor is an "accredited investor" as defined in Regulation
D under the Act and was not formed for the purpose of acquiring the Purchased
Shares or Conversion Shares or any New Securities; and

          (h) No person has or will have, as a result of any transaction
contemplated by this Agreement, any right, interest or claim against or upon the
Company or any of its Subsidiaries for any commission, fee or other compensation
as a finder or broker because of any act or omission by such Investor.

     6.2  Permitted Sales; Legends.  Notwithstanding the foregoing
          ------------------------
representations, the Company agrees that it will permit, (i) a transfer of
Purchased Shares, Conversion Shares or New Securities by an Investor that is a
partnership to one or more of its partners, where no consideration is exchanged
therefor by such partners, or to a retired or withdrawn partner who retires or
withdraws after the date hereof in full or partial distribution of his interest
in such

                                       16
<PAGE>

partnership, or to the estate of any such partner or the transfer by gift, will
or intestate succession of any partner to his spouse or to the siblings, lineal
descendants or ancestors of such partner or his spouse, or to a trust created
for the benefit of one or more of the foregoing, if the transferee prior to such
transfer, executes and delivers to the Company a Confidentiality Agreement
substantially in the form attached hereto as Exhibit G and agrees in writing to
                                             ---------
be subject to the duties and obligations hereof to the same extent as if it were
an original Investor hereunder and (ii) a sale or other transfer of any of the
Purchased Shares, Conversion Shares or New Securities, in each case covered by
clause (i) or (ii) upon obtaining assurance satisfactory to the Company prior to
any such sale or other transfer that such transaction is exempt from the
registration requirements of, or is covered by an effective registration
statement under, the Act and applicable state securities or "blue-sky" laws,
including, without limitation, receipt of an unqualified opinion to such effect
of counsel reasonably satisfactory to the Company. Notwithstanding anything to
the contrary herein, except in accordance with the Shareholders Agreement, no
distribution, sale or transfer of Purchased Shares, Conversion Shares, Common
Stock or any other interest of the Company shall be made by any Investor, or its
successor, transferee, trustees or assigns, whether pursuant to this Section 6.2
or otherwise, to any competitor of the Company (as determined in said
Shareholders Agreement).

     The certificates representing the Purchased Shares and any Conversion
Shares issuable upon conversion thereof, and any New Securities acquired by an
Investor, or by any successor, transferee or assignee, shall bear a legend
evidencing such restriction on transfer substantially in the following form:

          "The shares represented by this certificate have been acquired for
          investment and have not been registered under the Securities Act of
          1933, as amended (the "Act") or the securities laws of any state, and
          are subject to certain restrictions on transfer set forth in an
          agreement dated September 30, 1997 between the corporation and the
          holder of these shares.  In addition to compliance with said
          restrictions, the shares may not be transferred by sale, assignment,
          pledge or otherwise unless (i) a registration statement for the shares
          under the Act is in effect or (ii) the corporation has received an
          opinion of counsel, which opinion is reasonably satisfactory to the
          corporation, to the effect that such registration is not required
          under the Act."

     6.3    Confidentiality Agreement.  Each Investor has duly authorized,
            -------------------------
executed and delivered to the Company a Confidentiality Agreement substantially
in the form attached hereto as Exhibit G.
                               ---------

     6.4    Mandatory Conversion.  The Investors acknowledge that the Series A
            --------------------
Preferred Stock will be subject to mandatory conversion into Common Stock upon
the occurrence of a Qualified Public Offering in accordance with the terms of
the Amended and Restated Certificate of Incorporation attached hereto as Exhibit
                                                                         -------
A.
-

                                       17
<PAGE>

                                  ARTICLE VII
                      CONDITIONS OF INVESTORS' OBLIGATION
                      -----------------------------------

     7.1    Effect of Conditions.  The obligation of the Investors to purchase
            --------------------
and pay for the Purchased Shares at the Closing shall be subject to the
satisfaction of each of the conditions stated in the following Sections of this
Article, unless waived by the Investors.

     7.2    Representations and Warranties.  The representations and warranties
            ------------------------------
of the Company contained in this Agreement shall be true and correct on the date
of  Closing with the same effect as though made on and as of that date, and the
Investors shall have received a certificate dated as of such Closing and signed
on behalf of the Company to that effect.

     7.3    Performance.  The Company shall have performed and complied with all
            -----------
of the agreements, covenants and conditions contained in this Agreement required
to be performed or complied with by it at or prior to such Closing, and the
Investors shall have received a certificate dated as of such Closing and signed
on behalf of the Company to that effect.

     7.4    Certified Documents, etc.  The Investors shall have received a copy
            ------------------------
of the Company's Certificate of Incorporation, as amended, certified by the
Secretary of State of the State of Delaware and copies of the Company's By-Laws
certified by its Secretary, as well as any and all other documents, including
certificates as to votes adopted and incumbency of officers and certificates
from appropriate authorities as to the legal existence and tax good standing of
the Company, and an opinion of counsel to the Company, which the Investors or
their counsel may reasonably request.

     7.5    No Material Adverse Change.  The business, properties, assets or
            --------------------------
condition (financial or otherwise) of the Company shall not have been materially
adversely affected since the date of this Agreement, whether by fire, casualty,
act of God or otherwise, and there shall have been no other changes in the
business, properties, assets, condition (financial or otherwise), management or
prospects of the Company that would have a material adverse effect on the
business or assets of the Company.

     7.6    Shareholders' Agreement.  A Shareholders' Agreement substantially in
            -----------------------
the form of Exhibit C attached hereto shall have been executed by each Investor,
            ---------
the Company and the shareholders named as parties therein.

     7.7    Reserved.
            --------

     7.8    Registration Rights Agreement.  The Registration Rights Agreement
            -----------------------------
shall have been executed by the Company, each of the Investors and the other
persons named as parties therein.

                                       18
<PAGE>

     7.9    Amendment to Certificate of Incorporation.  The Certificate of
            -----------------------------------------
Incorporation of the Company shall have been amended and restated to provide
for, among other things, the authorization of the Series A Preferred Stock with
the terms set forth in the Certificate of Incorporation attached as Exhibit A
                                                                    ---------
hereto.

     7.10   Non-Competition Agreements.  Each of Marc A. Cohen and Alain J.
            --------------------------
Cohen shall have executed a Non-Competition Agreement substantially in the form
attached as Exhibit F hereto.
            ---------

     7.11   Board Election.  Concurrently with the Closing, the Board of
            --------------
Directors of the Company shall, except in respect of an independent director,
have been constituted in accordance with Section 5.5 and the Shareholders
Agreement.

     7.12   Consents and Waivers.  The Company shall have obtained all consents
            --------------------
or waivers necessary, at the time of the Closing, to execute this Agreement and
the other agreements and documents contemplated herein, to issue the Purchased
Shares and the Conversion Shares, and to carry out the transactions contemplated
hereby and thereby. All corporate and other action and governmental filings
necessary at the time of the Closing to effectuate the terms of this Agreement,
the Related Agreements, and other agreements and instruments executed and
delivered by the Company in connection herewith, and to issue and sell the
Purchased Shares and the Conversion Shares, shall have been made or taken.

                                 ARTICLE VIII
                    CONDITIONS OF THE COMPANY'S OBLIGATION
                    --------------------------------------

     The Company's obligation to sell the Purchased Shares shall be subject to
(a) the compliance and performance by the Investors with all of the agreements,
covenants and conditions contained in this Agreement and required to be
performed or complied with by the Investors at or before the Closing and to
accuracy on the date of the Closing of the representations and warranties of the
Investors contained in this Agreement, and (b) the execution and delivery by the
Investors with, the Shareholders Agreement and the Confidentiality Agreement
substantially in the form of Exhibits C and G attached hereto.
                             ----------     -

                                  ARTICLE IX
                              CERTAIN DEFINITIONS
                              -------------------

     As used in this Agreement, the following terms shall have the following
meanings (such meanings to be equally applicable to both the singular and plural
forms of the terms defined):

     "Act" means the Securities Act of 1933, as amended.

     "Agreement" means this Series A Preferred Stock Purchase Agreement as from
time to time amended and in effect among the parties.

                                       19
<PAGE>

     "Applicable Conversion Value" shall mean the Applicable Conversion Value of
the Series A Preferred Stock under Section 5(c) of Article V of Exhibit A
                                                                ---------
attached hereto.

     "Closing" shall have the meaning set forth in Section 1.3.

     "Commission" shall have the meaning set forth in Section 2.3.

     "Common Stock" means (a) the Company's Common Stock as authorized on the
date of this Agreement, (b) any other capital stock of any class or classes of
the Company authorized on or after the date hereof, the holders of which shall
have the right, without limitation as to amount, either to all or to a share of
the balance of current dividends and liquidating dividends after the payment of
dividends and distributions on any shares entitled to preference, provided that
                                                                  --------
Common Stock shall not include any shares of Series A Preferred Stock, and (c)
any other securities of the Company into which or for which any of the
securities described in (a) or (b) may be converted or exchanged pursuant to a
plan of recapitalization, reorganization, merger, sale of assets or otherwise.

     "Company" means and shall include MIL 3, Incorporated, a Delaware
corporation, and its successors and assigns.

     "Conversion Shares" shall have the meaning set forth in Section 1.2.

     "Indebtedness" means all obligations, contingent and otherwise, for
borrowed money which are required to be reflected as indebtedness on a balance
sheet prepared in accordance with generally accepted accounting principles
including, without limitation, any current portion of long-term indebtedness and
all guaranties, endorsements and other contingent obligations in respect of
indebtedness of others except guaranties by endorsement of negotiable
instruments for deposit or collection or similar transactions in the ordinary
course of business.

     "Investor" shall have the meaning set forth in Section 1.1.

     "Knowledge," "known" and words of similar import when used in respect of
the Company mean and include only the actual conscious awareness or knowledge of
the senior executive officers of the Company.

     "New Securities" shall have the meaning set forth in Section 5.2.

     "Person" means an individual, corporation, partnership, joint venture,
trust or unincorporated organization or a government or agency or political
subdivision thereof.

     "Purchased Shares" shall have the meaning set forth in Section 1.1.

                                       20
<PAGE>

     "Qualified Public Offering" means the closing of a public offering by the
Company pursuant to a registration statement filed and declared effective under
the Act covering the offer and sale of Common Stock in which the aggregate gross
proceeds are over $20 million and in which the price per share of Common Stock
equals or exceeds three times the then Applicable Conversion Value of the Series
A Preferred Stock determined pursuant to Exhibit A attached hereto.
                                         ---------

     "Related Agreements" shall have the meaning set forth in Section 2.2.

     "Series A Preferred Stock" shall have the meaning set forth in Section 1.1.

     "Subsidiary" or "Subsidiaries" means any corporation, association or other
business entity of which the Company and/or any of its other Subsidiaries (as
herein defined) directly or indirectly owns at the time more than fifty percent
(50%) of the outstanding voting shares of every class of such corporation,
association or other business entity other than directors' qualifying shares.

                                       21
<PAGE>

                                   ARTICLE X
                                  TERMINATION

     10.1   Termination by Mutual Written Consent.  This Agreement may be
            -------------------------------------
terminated, and the transactions contemplated hereby abandoned, at any time
prior to the Closing by the written agreement of the Company and the Investors.

     10.2   Termination for Breach or Failure to Satisfy Conditions.  This
            -------------------------------------------------------
Agreement may be terminated and the transactions contemplated hereby may be
abandoned at any time before the Closing (or any date to which the Closing may
have been extended by the written agreement of the parties obligated to perform
on such Closing) by any party obligated to perform on the Closing if the
conditions for its benefit set forth in Article VII or VIII, as the case may be,
have not been satisfied on or prior to the Closing (or any such extended date
for Closing) and if the conditions for the benefit of the other parties have
been satisfied or waived, and if such performing party shall have given written
notice of termination to the non-performing party.

     10.3   Termination for Delay.  Unless earlier terminated in accordance with
            ---------------------
Section 10.1 or 10.2, this Agreement may be terminated and the transactions
contemplated hereby may be abandoned by the Company or the Investors if the
Closing does not occur by October 31, 1997, provided, however, that the right to
                                            --------  -------
terminate this Agreement under this Section 10.3 shall not be available to any
party whose failure to fulfill any obligation under this Agreement has been the
cause of, or resulted in, the failure of the Closing to occur on or before such
date.

     10.4   Rights After Termination.  Upon termination of this Agreement under
            ------------------------
this Article X, the parties shall be released from all obligations arising
hereunder, except as to any liability for misrepresentations, breach or default
in connection with any warranty, representation, covenant, duty or obligation
given, occurring or arising prior to the date of termination and except as to
the parties' obligations under Section 11.6 hereof.

                                  ARTICLE XI
                                 MISCELLANEOUS

     11.1   Survival of Representations.  The representations, warranties,
            ---------------------------
covenants and agreements made herein or in any certificates or documents
executed in connection herewith shall survive the execution and delivery hereof
and the closing of the transaction contemplated hereby, and shall terminate as
to any such representations or warranties by the Company on the earlier of
January 1, 1999 or thirty (30) days after the delivery by the Company of an
unqualified audit report on the Company's financial statements for the year
ended March 31, 1998, provided, however, that the representations in (a)
                      --------  -------
Sections 2.4 and 2.22 shall terminate on the third anniversary of the Closing,
and (b) Section 2.10 shall terminate on the expiration of the applicable
limitations period for the subject tax return.

                                       22
<PAGE>

     11.2   Parties in Interest.  Except as otherwise set forth herein, all
            -------------------
covenants, agreements, representations, warranties and undertakings contained in
this Agreement shall be binding on and shall inure to the benefit of the
respective successors and assigns of the parties hereto (including transferees
of any of the Purchased Shares or Conversion Shares). The parties agree to
maintain in confidence the terms of the purchase of the Purchased Shares
hereunder, except that the Investors may disclose such terms to the partners in
the Investors in the ordinary course and except that the Company may disclose
such terms to its shareholders and outside advisors in the ordinary course and
in connection with any filing or information required to be submitted to any
governmental agency.

     11.3   Shares Owned by Affiliates.  For the purposes of applying all
            --------------------------
provisions of this Agreement which condition the receipt of information or
access to information upon ownership of a specified number or percentage of
shares, the shares owned of record by any affiliate of a Investor shall, if such
affiliate has complied with all requirements under this Agreement relating to
the transfer of such shares, be deemed to be owned by such Investor.  For the
purpose of this Agreement, the term "affiliate" shall mean any Person
controlling, controlled by or under common control with, an Investor and any
general or limited partner of an Investor at the date of this Agreement.
Without limiting the foregoing, each Investor shall be considered an affiliate
of each other Investor.

     11.4   Amendments and Waivers.  Amendments or additions to this Agreement
            ----------------------
may be made, agreements with any decision of the Company may be made, and
compliance with any term, covenant, agreement, condition or provision set forth
herein may be omitted or waived (either generally or in a particular instance
and either retroactively or prospectively) upon the written consent of the
Company and the holders of a majority of the outstanding Purchased Shares.
Prompt notice of any such amendment or waiver shall be given to any party hereto
who did not consent to such amendment or waiver.  This Agreement (including the
Schedules and Exhibits annexed hereto, which are an integral part of this
Agreement) constitutes the full and complete agreement of the parties with
respect to the subject matter hereof.

     11.5   Notices.  All notices, requests, consents, reports and demands shall
            -------
be in writing and shall be hand delivered, or mailed, postage prepaid, to the
Company or to the Investors at the address set forth below or to such other
address as may be furnished in writing to the other parties hereto:

     The Company:           MIL 3, Incorporated
                            3400 International Drive, N.W.
                            Washington, D.C. 20008
                            Attn:  Marc A. Cohen, Chairman of
                                   the Board and Chief Executive
                                   Officer

                                       23
<PAGE>

     with copy to:          Verner, Liipfert, Bernhard, McPherson
                            & Hand, Chartered
                            Suite 700
                            901 15th Street, N.W.
                            Washington, D.C. 20005
                            Attn: Harold I. Freilich, Esquire

     The Investors:         Summit Ventures IV, L.P.
                            Summit Investors III, L.P.
                            c/o Summit Partners
                            600 Atlantic Avenue
                            Suite 2800
                            Boston, Massachusetts 02210
                            Attn: Bruce R. Evans

     with copy to:          Hutchins, Wheeler & Dittmar,
                            A Professional Corporation
                            101 Federal Street
                            Boston, MA 02120
                            Attention:  James Westra, Esquire

Notices given in accordance with the foregoing shall be deemed received (i) upon
receipt, if hand delivered, and (ii) five business days after deposited in the
U.S. mail, if sent by mail.

     11.6   Expenses.  Each party hereto will pay its own expenses in connection
            --------
with the transactions contemplated hereby, provided, however, that if the
                                           --------  -------
purchase of Series A Preferred Stock by the Investor is consummated, the Company
shall pay all reasonable legal expenses (including fees and disbursements)
actually incurred by the Investors in connection with the purchase of the Series
A Preferred Stock, including in connection with the investigation, preparation,
execution and delivery of this Agreement (and due diligence related thereto) and
the other instruments and documents to be delivered hereunder and the
transactions contemplated hereby and thereby, in an aggregate amount not to
exceed $25,000.

     11.7   Counterparts.  This Agreement and any Exhibit hereto may be executed
            ------------
in multiple counterparts, each of which shall constitute an original but all of
which shall constitute but one and the same instrument.  One or more
counterparts of this Agreement or any Exhibit hereto may be delivered via
telecopier, with the intention that they shall have the same effect as an
original counterpart hereof.

     11.8   Effect of Headings.  The Article and Section headings herein are for
            ------------------
convenience only and shall not affect the construction hereof.

                                       24
<PAGE>

     11.9   Adjustments.  All provisions of this Agreement shall be
            -----------
automatically adjusted to reflect any stock dividend, stock split or other such
form of recapitalization.

     11.10  Governing Law.  This Agreement shall be deemed a contract made under
            -------------
the laws of the State of New York and together with the rights and obligations
of the parties hereunder, shall be construed under and governed by the laws of
such State.

                           [Signatures on next page]

                                       25
<PAGE>

     If you are in agreement with the foregoing, please sign in the space
indicated below and return this letter to the Company, whereupon this letter
shall become a binding agreement among us.

                                Very truly yours,

                                MIL 3, INCORPORATED

                                By:  /s/ Alain Cohen
                                     --------------------------------
                                     Name:  Alain Cohen
                                     Title: President

                                INVESTORS:

                                SUMMIT VENTURES IV, L.P.

                                By: Summit Partners IV, L.P.
                                    Its General Partner

                                    By:  Stamps, Woodsum & Co. IV
                                         Its General Partner

                                         By: /s/ Bruce R. Evans
                                             ------------------
                                             General Partner

                                SUMMIT INVESTORS III, L.P.

                                         By: /s/ Bruce R. Evans
                                             -----------------------
                                             General Partner
<PAGE>

                                 Schedule 1.1

            List of Investors and Number of Shares to be Purchased
            ------------------------------------------------------

<TABLE>
<CAPTION>
Investor                       Number of Purchased Shares         Aggregate Purchase Price
--------                       --------------------------         ------------------------
<S>                            <C>                                <C>
Summit Ventures IV, L.P.              138,422 Shares                    $6,699,627

Summit Investors III, L.P.              6,218 Shares                       300,949
                                      --------------                    ----------
                                      144,640 Shares                    $7,000,576
                                      ==============                    ==========
</TABLE><PAGE>

                                                                    EXHIBIT 10.2

     SHAREHOLDERS AGREEMENT (the "Agreement") made as of the 30th day of
September, 1997, by and among SUMMIT VENTURES IV, L.P. ("Summit Ventures"), a
Delaware limited partnership; SUMMIT INVESTORS III, L.P. ("Summit Investors"), a
Delaware limited partnership; MARC A. COHEN ("M. Cohen"), an individual residing
in Washington, D.C.; and ALAIN J. COHEN ("A. Cohen"), an individual residing in
Washington, D.C. (Summit Investors and Summit Ventures are each sometimes
referred to herein as an "Investor" and collectively as the "Investors"; A.
Cohen and M. Cohen are each sometimes referred to herein as a "Current
Shareholder" and collectively as the "Current Shareholders"; and all of the
parties hereto are sometimes referred to herein individually as a "Shareholder"
and collectively as the "Shareholders.")

                                  WITNESSETH:

     WHEREAS, in accordance with a Series A Preferred Stock Purchase Agreement
(the "Purchase Agreement") dated as of September 30, 1997, among the Investors
and MIL 3, Incorporated (the "Company"), (a) Summit Investors has purchased from
the Company a total of 6,218 shares of the Company's Series A Convertible
Preferred Stock, par value $.001 per share (the "Series A Preferred Stock"), and
(b) Summit Ventures has purchased from the Company a total of 138,422 shares of
the Series A Preferred Stock; and

     WHEREAS, A. Cohen currently owns 400,000 shares of the Company's Common
Stock, par value $.01 per share (the "Common Stock"), and M. Cohen currently
owns 250,000 shares of the Common Stock; and

     WHEREAS, it is a condition to the obligations of the Company and the
Investors under the Purchase Agreement that this Agreement be executed and
delivered by the parties hereto, and the parties are willing to execute and
deliver this Agreement and to be bound by the provisions hereof.

     NOW, THEREFORE, in consideration of the foregoing, the agreements set forth
below, and the parties' desire to provide for continuity of ownership of the
Company to further the interests of the Company and its present and future
shareholders, the parties hereby agree with each other as follows:

     1.   Certain Definitions.   The term "Shares" shall mean and include, when
          -------------------
used in respect of (a) a Current Shareholder, all shares of Common Stock owned
by such Shareholder at the time of determination, and (b) an Investor, all
shares of Series A Preferred Stock owned by such Investor at the time of
determination and all shares of Common Stock which such Investor may at such
time own and thereafter acquire in connection with conversion of such Series A
Preferred Stock.  Other terms used with initial capital letters and not defined
herein shall have the meanings set forth in the Purchase Agreement.
<PAGE>

     2.   Restriction on Transfers.
          ------------------------

     (a)  No Shareholder shall Transfer all or any of its Shares except in
compliance with this Agreement, and any attempted Transfer of any Shares in
contravention of this Agreement shall be void and of no force and effect.

     (b)  The term "Transfer" shall mean and include any sale, exchange,
assignment, disposition, bequest, gift, pledge, mortgage, hypothecation, or
other disposition, whether voluntary, involuntary or by operation of law, and
whether resulting from death, bankruptcy, insolvency or otherwise.

     (c)  Notwithstanding anything to the contrary contained in this Agreement:

          (i)  each Current Shareholder may Transfer, without the necessity to
     comply with Section 3 or 4, any or all of his Shares

               (x)  by way of gift to his spouse, to any of his lineal
          descendants or ancestors, or to any trust for the benefit of any one
          or more of such Current Shareholder, his spouse or his lineal
          descendants or ancestors, as long as the aggregate amount of all such
          Transfers  contemplated by this clause (x) by such Current Shareholder
          does not exceed 20% of the Shares held by such Shareholder on the date
          hereof (after giving effect to the Company's repurchase of 30,000
          shares of Common Stock from A. Cohen and 20,833 shares of Common Stock
          from M. Cohen in accordance with those certain Stock Repurchase
          Agreements dated as of September 30, 1997, between the Company, on one
          hand, and each of A. Cohen and M. Cohen, on the other hand, and as
          adjusted for any stock splits, stock dividends or other
          recapitalizations), or

               (y)  to the other Current Shareholder in accordance with a
          written agreement to be entered between them governing the purchase
          and sale of his Shares upon death, or

               (z)  in a public offering registered under the Securities Act of
          1933, as amended (the "Act"); and

          (ii) each Current Shareholder may Transfer any or all of his Shares by
     will or the laws of descent and distribution (each of the Transfers
     contemplated in this clause (ii) and in clause (i) above is hereinafter
     sometimes referred to as a "Permitted Transfer" and each such transferee as
     a "Permitted Transferee.");

provided, however, that any such transferee under clause (i) or (ii) of this
--------  -------
Section 2(c) (other than a transferee in a public offering as contemplated
above) shall, if it has not already done so, agree in writing with the other
Shareholders, as a condition to such transfer, to be bound by all of the
provisions of this Agreement to the same extent as if such transferee were the
Current Shareholder Transferring such Shares.

                                       2
<PAGE>

     (d)  Except as otherwise expressly provided herein, neither Investor may
Transfer any of its Shares to any "competitor" (as hereafter defined) of the
Company without first obtaining the written consent of the Current Shareholders.
The term "competitor" shall mean (x) each of Systems & Networks (otherwise known
as the "Alta Group"), SES, CACI, Make Systems, Networks Analysis Center, Network
General, Cadence, Mentor Graphics, Bay Networks, Optimal Networks, Netsys
Technologies, Cisco, Netstuite, ImageNet, Ltd., GRC International (GRCI), Inc.,
TeleniX Corporation, Network Tools and NetFusion and (y) any other person,
entity, division or project that is or intends to be engaged in investigating,
developing, marketing, selling, investing in or otherwise commercially
exploiting any product or services substantially similar to any product or
service that the Company or any of its affiliates is or intends to be engaged in
investigating, developing, marketing, selling, investing in or otherwise
commercially exploiting.  No person shall be deemed to be a competitor of the
Company solely by virtue of the fact that such person owns one percent (1%) or
less of the outstanding shares of another person whose securities are publicly
traded and who is a competitor of the Company,  provided that the owner of such
                                                --------
shares is not an affiliate of  such competitor.

          (i)   Prior to any proposed Transfer, the subject Investor shall
     provide notice to the Current Shareholders and the Company of the number of
     Shares proposed to be transferred and the name of, and reasonably
     sufficient information concerning, the proposed transferee (including,
     without limitation, information concerning the lines of business of such
     proposed transferee and a signed, written representation from the
     transferee that it is not a competitor (as defined above) of the Company)
     so as to enable the Board of Directors of the Company to determine whether
     or not such proposed transferee is a competitor of the Company.

          (ii)  The Board shall, within 10 days after receipt of all of such
     information, advise the Investor of its determination as to whether or not
     such proposed transferee is a competitor of the Company.

          (iii) Following the expiration of the 10 day period referred to in
     clause (ii) above, the subject Investor may transfer any of its Shares to
     the proposed transferee unless the Board has advised the Investor within
     such 10 day period (x) of the Board's determination that the proposed
     transferee is a competitor of the Company or (y) that the Investor has
     failed to provide the Board with sufficient information to make such
     determination.

          (iv)  Notwithstanding anything to the contrary herein, the Investors
     may not transfer any Shares to any person identified in clause (x) of the
     second sentence of Section 2(d) unless (1) the Board affirmatively consents
     thereto in writing or (2) either of the Current Shareholders has or is then
     transferring any of his Shares to such identified person.

          (v)   If the Investor provides notice to the Company, (1) within five
     days of the Investor's receipt of the Board's determination, that the
     Investor disagrees with the determination that the proposed transferee is a
     competitor of the Company, or (2) within five days of the Investor's second
     submission to the Board of information concerning the proposed transferee,
     that the Investor believes it has furnished reasonably sufficient
     information to the Board concerning the proposed transferee, then the
     Investor and a representative of the Board

                                       3
<PAGE>

     shall meet within five days of such notice to seek to resolve such
     disagreement. If such disagreement cannot be resolved within five days of
     such meeting, then it shall, upon election by the Investor or the Board, be
     submitted to arbitration in accordance with the following procedures.

                (x)  Either the Investor or the representative of the Board may
     by written notice (the "Arbitration Notice") to the other, refer such
     disagreement for final settlement by arbitration in accordance with the
     commercial arbitration rules (the "Rules") then in force of the American
     Arbitration Association (the "AAA"), as modified by the procedures set
     forth herein. The arbitration shall be held in the Washington, D.C.
     metropolitan area.

                (y)  The arbitration shall be conducted by three arbitrators.
     Each of the representative of the Board and the Investor shall appoint one
     arbitrator, and each appointing party shall notify the other appointing
     party of the name of its appointee within five days of the date of the
     Arbitration Notice.  The two arbitrators so appointed shall together,
     within five days after the date on which the first two arbitrators were
     required to be appointed, appoint the third, presiding arbitrator.  If an
     arbitrator must be replaced for any reason, the party that appointed such
     arbitrator shall appoint a substitute arbitrator within 10 days of the date
     upon which such replacement became necessary.  If such appointing party
     fails to appoint any arbitrator (whether the original or replacement
     arbitrator, as the case may be) within the time limits provided hereunder,
     such arbitrator(s) shall, upon the written request of the other party to
     the arbitration that has made its appointment, be appointed by the
     presiding arbitrator.

                (z)  The arbitral panel shall determine a date on which it shall
     commence taking evidence, which date shall be not less than 10 days after
     the panel has been appointed.  The arbitral panel shall by a majority, in
     its absolute discretion, determine the course of action to be followed and
     its decision shall be issued in writing within 10 days after the conclusion
     of the relevant proceedings.  Any award of the arbitral panel shall be
     final and binding, and judgment upon any arbitral award may be entered and
     enforced by any court or judicial authority of competent jurisdiction.

          (vi)  Any transferee of Shares from an Investor as contemplated by
     this Section 2(d) shall, if it has not already done so, agree in writing
     with the other Shareholders, as a condition to such transfer, to be bound
     by this provisions of this Section 2(d).

          (vii) The restrictions in this Section 2(d) shall not limit or
     interfere with the right of the Investors to transfer Shares:

                (x)  in accordance with Section 4 to a Proposed Purchaser (as
          defined in Section 4); or

                (y)  to any other person to whom a Current Shareholder has or is
          then transferring Shares, whether directly or in connection with any
          merger or other business combination transaction involving the
          Company.

                                       4
<PAGE>

     (e)  All certificates evidencing the Shares shall have the following
legend, in addition to any legend required by the Purchase Agreement:

          "THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AND ARE
          TRANSFERRABLE ONLY UPON COMPLIANCE WITH THAT CERTAIN SHAREHOLDERS
          AGREEMENT DATED AS OF SEPTEMBER 30, 1997, A COPY OF WHICH IS ON FILE
          WITH THE CORPORATE SECRETARY OF MIL 3, INCORPORATED. THE SHARES
          REPRESENTED BY THIS CERTIFICATE MAY NOT BE TRANSFERRED OR OTHERWISE
          DISPOSED OF EXCEPT IN COMPLIANCE WITH SUCH AGREEMENT."

     A copy of this Agreement shall be delivered to the corporate secretary of
the Company, and shall be shown to any person identified by a Shareholder in
writing to the corporate secretary.

     3.   Right of First Offer on Transfer by Current Shareholder.
          -------------------------------------------------------

     (a)  Except for Permitted Transfers, a Current Shareholder may only
Transfer his Shares after satisfaction of each of the following conditions.

     (b)  If a Current Shareholder desires to Transfer any of his Shares in any
transaction that does not constitute a Permitted Transfer, such Shareholder (the
"Offering Shareholder") shall first provide written notice (the "Offer Notice")
to each Investor of the number of Shares that he proposes to Transfer (the
"Offered Shares"), the floor cash purchase price therefor (the "Floor Price")
and the other terms of the proposed sale. The Offer Notice shall constitute a
conditional irrevocable offer to sell a pro rata portion (as hereinafter
                                        --- ----
determined) of the Offered Shares to each Investor in accordance with this
Section 3 at the Floor Price.  An Investor's pro rata portion of the Offered
                                             --- ----
Shares shall be equal to the product of (i) the number of Offered Shares, times
(ii) a fraction, (x) the numerator of which is the number of Shares then owned
by such Investor and (y) the denominator of which is the total number of Shares
then owned by both Investors.

     (c)  Each Investor shall have 30 days from the date of delivery of the
Offer Notice (the "Offer Period") to deliver a written notice to the Offering
Shareholder accepting such offer on the terms specified therein; failure to
deliver such written acceptance within the Offer Period shall be deemed a
rejection of the Offer Notice. If an Investor accepts such offer, it shall,
within 60 days thereafter, purchase the Offered Shares in accordance with the
terms specified in the Offer Notice. In the event that an Investor fails to
purchase the Offered Shares in accordance with the preceding sentence, the
Offering Shareholder shall thereafter have the right to offer and sell such
Offered Shares on the terms and conditions specified in the Offer Notice without
first having to comply with the procedures specified in this Section 3.

     (d)  If an Investor does not accept the offer to purchase its pro rata
                                                                   --- ----
portion of the Offered Shares, the Offering Shareholder shall then have 60 days
from the date of the expiration of the Offer Period to offer such Shares to
another transferee at a price equal to or exceeding the Floor Price and to
conclude said transaction.  If the Offering Shareholder has not concluded said
transaction at the

                                       5
<PAGE>

termination of such 60-day period, then the Offering Shareholder shall, in
connection with any other Transfer (except a Permitted Transfer) again have to
comply with the provisions of this Section 3.

     (e)  The rights granted to the Investors in this Section 3 are not
transferable or assignable to any person.

     4.   Right of Participation in Certain Sales.
          ---------------------------------------

     (a)  Provided that the Investors together own at least 48,214 shares of
Series A Preferred Stock (as adjusted for stock splits, stock dividends and
other recapitalizations), if at any time either Current Shareholder who,
together with such Current Shareholder=s spouse, lineal descendants and
ancestors, and any trust for the benefit of such Current Shareholder, his
spouse, lineal descendants or ancestors, then holds more than 10% of the sum of
all of the issued and outstanding Shares of Common Stock and of the number of
shares of Common Stock issuable upon conversion of all outstanding shares of
Series A Preferred Stock proposes to sell, dispose of or otherwise transfer for
cash, in a single transaction or a series of related bona fide transactions
                                                     ---- ----
(other than a Permitted Transfer) with any person, any shares of Common Stock
which, together with all other transfers, sales and dispositions by such Current
Shareholder to persons in transactions other than Permitted Transfers, exceed
37,000 shares of Common Stock in the case of A. Cohen, or 22,916 shares of
Common Stock in the case of M. Cohen, in each case as adjusted for stock splits,
stock dividends or other recapitalizations (each such Current Shareholder, to
the extent such sale, transfer or disposition exceeds such applicable amount, is
herein referred to as a "Disposing Shareholder"), the Disposing Shareholder
shall, unless the Investors have purchased all of such Shares in accordance with
Section 3,  refrain from effecting such transaction unless, prior to the
consummation thereof, the Investors shall have been afforded the opportunity to
join in such sale, disposition or transfer on a pro rata basis, as hereinafter
                                                --- ----
provided.

     (b)  Prior to the consummation of any transaction subject to this Section 4
with respect to a particular number of the Shares then owned by the Disposing
Shareholder (the "Disposition Amount"), the Disposing Shareholder shall cause
the person who proposes to acquire such Shares (the "Proposed Purchaser") to
offer (the "Purchase Offer") in writing to each Investor to purchase shares of
Common Stock that would be owned by such Investor upon conversion of such
Investor's Series A Preferred Stock, such that the aggregate number of shares of
Common Stock to be so purchased from each Investor shall be not less than the
number equal to the product of (i) the Disposition Amount multiplied by (ii) a
fraction, (x) the numerator of which is the total number of shares of Common
Stock issuable to such Investor upon conversion of all of the Series A Preferred
Stock then owned by such Investor and (y) the denominator of which is the sum of
(1) the total number of shares of Common Stock issuable to both Investors upon
conversion of all of the Series A Preferred Stock then owned by both Investors
plus (2) the total number of shares of Common Stock then owned by the Disposing
Shareholder.  Such purchase shall be made at the highest price per share and on
such other terms and conditions as the Proposed Purchaser has offered to
purchase shares of Common Stock from  the Disposing Shareholder, and the
aggregate number of shares of Common Stock purchased by the Proposed Purchaser
from the Disposing Shareholder and the Investor(s) shall equal the Disposition
Amount.

                                       6
<PAGE>

     (c)  Each Investor shall have 20 days from the receipt of the Purchase
Offer in which to provide written notice that it accepts such Purchase Offer;
failure to deliver such written acceptance within such period shall be deemed a
rejection of such Purchase Offer. If the Purchase Offer is accepted in
accordance with the foregoing, the closing of such purchase shall occur within
15 days after such acceptance or at such other time as such Investor, the
Disposing Shareholder and the Proposed Purchaser may agree. Each Investor that
desires to participate in such sale as contemplated herein shall, on or prior to
closing of such sale, convert into Common Stock that number of shares of its
Series A Preferred Stock as shall equal the number of shares of Common Stock to
be sold by it at such closing to the Proposed Purchaser.

     (d)  In the event that a sale, disposition or other transfer subject to
this Section 4 is to be made to a Proposed Purchaser who is not a Permitted
Transferee, the Disposing Shareholder shall notify the Proposed Purchaser that
the sale, disposition or other transfer is subject to this Section 4 and shall
ensure that no sale, disposition or other transfer by the Disposing Shareholder
is consummated without the Proposed Purchaser first complying with this Section
4.

     (e)  The rights granted to the Investors in this Section 4 are not
transferable or assignable to any person.

     5.   Election of Directors and Compensation Committee.
          ------------------------------------------------

     (a)  At each annual meeting of the shareholders of the Company, and at each
special meeting of the shareholders of the Company called for the purpose of
electing directors of the Company, and at any time at which shareholders of the
Company shall have the right to, or shall, vote for election of directors of the
Company, then, and in each event, the Shareholders shall vote all Shares owned
by them for the election of a Board of Directors consisting of not more than
seven directors, two of which directors shall be designated as follows:

          (i)  one director shall be designated jointly by the Investors (which
     designee shall initially be Bruce R. Evans and whose successor, if any,
     shall either be (x) a general partner or officer of any entity which
     controls either of  the Investors or (y) a person of good business
     reputation experienced in telecommunications, networking or software; and

          (ii) one independent director, who shall not be an employee of the
     Company or affiliated with any Shareholder, shall be designated jointly by
     the Investors and the Current Shareholders.

     (b)  The Company shall pay all direct travel expenses incurred by any
director in connection with the attendance of Board functions.

     (c)  The Shareholders shall vote their shares so as to cause to be formed
two Compensation Committees of the Board of Directors (each a "Compensation
Committee") comprised of three directors.  One Compensation Committee shall
determine the compensation for A. Cohen and shall be comprised of M. Cohen and
the two directors designated in accordance with Section 5(a)(i) and (ii); the
other Compensation Committee shall determine the compensation for M. Cohen and
shall be

                                       7
<PAGE>

comprised of A. Cohen and the two directors designated in accordance with
Section 5(a)(i) and (ii). The overall compensation packages (including salary,
bonus, equity participation and benefits) for each of A. Cohen and M. Cohen
shall be established by the Compensation Committees at a minimum level not less
than each of their compensation levels as of the date of this Agreement as set
forth on Schedule A attached hereto. The Compensation Committee shall, by
         ----------
majority vote of its members, not less frequently than annually, determine what
level of compensation for each of A. Cohen and M. Cohen in excess of that
specified on Schedule A is appropriate.
             -------- -

     (d)  The Shareholders shall use their best efforts to appoint the
independent director referred to in Section 5(a)(ii) as soon as practicable
following the Closing.

     (e)  The provisions of Section 5(a), (b), (c) and (d)  shall apply only so
long as the Investors (not including any transferee or assignee of either
Investor) together hold at least 48,214 shares of Series A Preferred Stock, as
adjusted for stock splits, stock dividends and other recapitalizations.

     (f)  The Shareholders agree, as long as the Investors together hold at
least 7,230 shares of Series A Preferred Stock (as adjusted for stock splits,
stock dividends and other recapitalizations), and provided that the Current
Shareholders and their affiliates own more than 50% of the sum of the number of
shares of Common Stock outstanding plus the number of shares of Common Stock
issuable upon conversion of the then outstanding shares of Series A Preferred
Stock, to provide the Investors with at least one (1) days= advance notice of
any action taken by the Current Shareholders by written consent in reliance upon
Section 228 of the Delaware General Corporation Law.

     6.   Term.  This Agreement shall terminate immediately prior to the
          ----
effective date of the first registration statement on Form S-1 filed by the
Company under the Act.  In addition, the provisions of Section 2(a), (b) and (c)
(but not  Section 2(d)), and of Section 3, shall terminate (if not already
terminated)  on the first date on which the Investors together hold less than
7,230 shares of Series A Preferred Stock (as adjusted for stock dividends, stock
splits and other recapitalizations).

     7.   Miscellaneous.
          -------------

     (a)  Amendments and Waivers.  Amendments or additions to this Agreement may
          ----------------------
be made, and compliance with any term, covenant, agreement, condition or
provision set forth herein may be omitted or waived (either generally or in a
particular instance and either retroactively or prospectively) upon the written
consent of each of the parties.

     (b)  Notices. All notices, requests, consents, reports and demands shall be
          -------
in writing and shall be hand delivered, or mailed, postage prepaid, to the
Company, the Current Shareholders and to the Investors at the addresses set
forth below, or to such other address as may be furnished in writing by a party
to the other parties hereto:

          If to the Company and/or the Current Shareholders:

               MIL 3, Incorporated
               3400 International Drive, N.W.

                                       8
<PAGE>

               Washington, D.C. 20008
               Attn: Marc A. Cohen, Chairman of
                     the Board of and Chief Executive
                     Officer

          with copy to:

               Verner, Liipfert, Bernhard, McPherson
               & Hand, Chartered
               Suite 700
               901 15th Street, N.W.
               Washington, D.C. 20005
               Attn: Harold I. Freilich, Esquire

          If to the Investors:

               c/o Summit Partners
               600 Atlantic Avenue
               Suite 2800
               Boston, MA  02210
               Attn: Bruce R. Evans

          with copy to:

               Hutchins, Wheeler & Dittmar
               A Professional Corporation
               101 Federal Street
               Boston, MA  02110
               Attn:  James Westra, Esquire

     Notices given in accordance with the foregoing shall be deemed received (i)
upon receipt, if hand delivered, and (ii) five business days after deposited in
the U.S. mail, if sent by mail.

     (c)  Entire Agreement.  This Agreement constitutes the entire agreement of
          ----------------
the parties with respect to the matters contemplated herein.  This Agreement
supersedes any and all prior understandings as to the subject matter of this
Agreement.

     (d)  Equitable Relief.  Each of the parties recognizes that the other
          ----------------
parties shall not have an adequate remedy at law if any party fails to comply
with the provisions of this Agreement, and that damages will not be readily
ascertainable, and each party expressly agrees that in the event of any failure
by it to comply with this Agreement, the other parties shall be entitled to seek
specific performance of its obligations hereunder and that it will not oppose an
application seeking such specific performance.

                                       9
<PAGE>

     (e)  Binding Effect; Assignment.  This Agreement shall be binding upon and,
          --------------------------
except as specified herein, inure to the benefit of the successors and assigns
of the respective parties hereto, provided, however, that each such successor
                                  --------  -------
and assign first executes and delivers to the other parties hereto a counterpart
of this Agreement.

     (f)  General; Definitions. The Section headings contained in this Agreement
          --------------------
are for reference purposes only and shall not in any way affect the meaning or
interpretation of this Agreement. Reference to the term "Section" herein is to a
Section of this Agreement. In this Agreement the singular includes the plural,
the plural the singular, and the use of any gender includes the neuter,
masculine and feminine genders.

     (g)  Severability. If any provision of this Agreement shall be found by any
          ------------
court of competent jurisdiction to be invalid or unenforceable, the parties
hereby waive such provision to the extent that it is found to be invalid or
unenforceable. Such provision shall, to the maximum extent allowable by law, be
modified by such court so that it becomes enforceable, and, as modified, shall
be enforced as any other provision hereof, with all the other provisions hereof
continuing in full force and effect.

     (h)  Counterparts. This Agreement may be executed in multiple counterparts,
          ------------
each of which shall constitute an original but all of which together shall
constitute one and the same instrument.

     (i)  Governing Law.  This Agreement shall be deemed a contract made under
          -------------
the laws of the State of New York and together with the rights and obligations
of the parties hereunder, shall be construed under and governed by the laws of
such State.

     (j)  Third Party Beneficiaries. This Agreement is made for the benefit of
          -------------------------
the parties hereto and shall not confer any rights or benefits on any person not
a party hereto.

                        [Signatures on following page]

                                       10
<PAGE>

     IN WITNESS WHEREOF, the parties have caused this Shareholders' Agreement to
be duly executed as of the date first above written.

                        /s/ Marc A. Cohen
                        ------------------------------
                        Marc A. Cohen

                        /s/ Alain J. Cohen
                        ------------------------------
                        Alain J. Cohen

                        SUMMIT VENTURES IV, L.P.

                              By:  Summit Partners IV, L.P.
                              Its: General Partner

                                   By:  Stamps, Woodsum & Co. IV
                                   Its: General Partner

                                   By: /s/ Bruce R. Evans
                                       --------------------
                                   Its:

                        SUMMIT INVESTORS III, L.P.

                              By: /s/ Bruce R. Evans
                                  -------------------------
                              Its: General Partner

The undersigned  hereby joins in the foregoing Agreement for purposes of
agreeing to comply with Sections 2(d), 5(b) and  7.

               MIL 3, Incorporated

               By: /s/ Marc A. Cohen
                   -----------------------
               Its:  Chairman
<PAGE>

                                  SCHEDULE A
                          Minimum Compensation Level
                          --------------------------

Alain J. Cohen: $270,000 per annum (salary and bonus) plus life, health and
disability insurance.

Marc A. Cohen: $270,000 per annum (salary and bonus) plus life, health and
disability insurance.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00003-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00003-of-00352.parquet"}]]